01 1Lusochimica SpA
01 1Sam-O Pharmaceutical Co., Ltd.
01 1Nimodipine
01 1Italy
Registrant Name : Sam-O Pharmaceutical Co., Ltd.
Registration Date : 2021-03-10
Registration Number : 20210310-209-J-534
Manufacturer Name : Lusochimica SpA
Manufacturer Address : Via Giotto 9, 23871 Lomagna (LC), Italy
26
PharmaCompass offers a list of Nimodipine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nimodipine manufacturer or Nimodipine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nimodipine manufacturer or Nimodipine supplier.
A Brainal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brainal, including repackagers and relabelers. The FDA regulates Brainal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brainal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Brainal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Brainal supplier is an individual or a company that provides Brainal active pharmaceutical ingredient (API) or Brainal finished formulations upon request. The Brainal suppliers may include Brainal API manufacturers, exporters, distributors and traders.
click here to find a list of Brainal suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Brainal Drug Master File in Korea (Brainal KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Brainal. The MFDS reviews the Brainal KDMF as part of the drug registration process and uses the information provided in the Brainal KDMF to evaluate the safety and efficacy of the drug.
After submitting a Brainal KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Brainal API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Brainal suppliers with KDMF on PharmaCompass.
